A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer.
Junjie ZhaoRuihuan QinHao ChenYupeng YangWenjun QinJing HanXuefei WangShifang RenYihong SunJianxin GuPublished in: Clinical proteomics (2020)
The nomogram achieved an individualized assessment of the risk of PM in GC patients; thus, the nomogram could be used to assist clinical decision-making before surgery.
Keyphrases
- lymph node metastasis
- end stage renal disease
- decision making
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- air pollution
- heavy metals
- coronary artery disease
- patient reported outcomes
- risk assessment
- high resolution
- mass spectrometry
- polycyclic aromatic hydrocarbons